Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease
- 5 September 2001
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 311 (1) , 1-4
- https://doi.org/10.1016/s0304-3940(01)02111-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-α, and HLA-DRB1 gene polymorphisms in human T-Cell lymphotropic virus type I associated myelopathyHuman Immunology, 2000
- Interleukin (IL)-1?, IL-1?, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsyAnnals of Neurology, 2000
- Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's diseaseNeuroscience Letters, 2000
- A new concept in neurodegeneration: TNFα is a silencer of survival signalsTrends in Neurosciences, 2000
- Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitusHuman Immunology, 1999
- Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: No association with narcolepsyAmerican Journal of Medical Genetics, 1999
- Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor‐α gene promoterTissue Antigens, 1998
- Polymorphism of the 5′‐flanking region of the human tumor necrosis factor (TNF)‐α gene in JapaneseTissue Antigens, 1998
- Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasisNeuron, 1994
- HLA‐DRB1 genotyping by modified PCR‐RFLP method combined with group‐specific primersTissue Antigens, 1992